Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Cleveland
State: Ohio
Zip:
Country: United States
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2008 | Series B | 2 | $8.4M |
Devon Park BioVentures Quaker BioVentures Devon Park BioVentures Quaker BioVentures |
10/2018 | Debt Financing | $12.1M | 9/2022 | Venture Round | $16.7M | 4/2009 | Debt Financing | $12.9M | 7/2017 | Venture Round | $0 |
Black Beret Life Sciences JDRF T1D Fund McDonald Partners Medicxi Black Beret Life Sciences JDRF T1D Fund McDonald Partners Medicxi |
3/2020 | Venture Round | $2.9M | 7/2017 | Venture Round | 4 | $30M |
Black Beret Life Sciences JDRF T1D Fund McDonald Partners Medicxi Black Beret Life Sciences JDRF T1D Fund McDonald Partners Medicxi |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|